Table 2 Etiology of valve-related mortality
From: Considerations for prostheses choice in multiple valve surgery
(Events, %/%/Pt-Year) | ||||||
|---|---|---|---|---|---|---|
Total | BP | MP | p value | |||
ATH | 17 (12.8%) | 8 (8.0%) | 0.16 | 9 (27.3%) | 0.27 | 0.270 |
NSD | 15 (11.3%) | 7 (7.0%) | 0.14 | 8 (24.2%) | 0.24 | 0.283 |
PVE | 21 (15.8%) | 15 (15.0%) | 0.29 | 6 (18.2%) | 0.18 | 0.292 |
SVD | 42 (31.6%) | 42 (42.0%) | 0.82 | 0 (0.0%) | 0.0 | < 0.0001 |
TE | 20 (15.0%) | 16 (16.0%) | 0.31 | 4 (12.1%) | 0.12 | 0.0603 |
TB | 3 (2.3%) | 1 (1.0%) | 0.02 | 2 (6.1%) | 0.06 | 0.3442 |
SUD | 15 (11.3%) | 11 (11.0%) | 0.21 | 4 (12.1%) | 0.12 | 0.2931 |
Total | 133 (100.0%) | 100 (100.0%) | 1.95 | 33 (100.0%) | 0.98 | 0.0003 |